0 items USD 0.00Search
Your search for "qyresearch global acute lymphoblastic leukemia therapeutics industry 2015 market research report" gave back 688394 results.
Market Analysis and Insights: Global Interleukin 1 Receptor Associated Kinase 4 Market The global Interleukin 1 Receptor Associated Kinase 4 market...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Hypoxia Inducible Factor 1 Alpha Inhibitor market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Adoptive Cell Transfer Therapy Market The global Adoptive Cell Transfer Therapy market is projected to grow from...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Blincyto is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Market Analysis and Insights: Global Chimeric Antigen Receptor Cell Therapy Market The global Chimeric Antigen Receptor Cell Therapy market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Leukemia Therapeutics market was valued at US$ 10920 million in 2023 and is anticipated to reach US$ 12890 million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
